The impracticality of surgically removing intramuscular long-acting injectable antipsychotic medication
Am J Emerg Med
.
2018 Mar;36(3):522-523.
doi: 10.1016/j.ajem.2017.08.012.
Epub 2017 Aug 4.
Authors
Edward Kim
1
,
Srihari Gopal
2
,
Amy O'Donnell
3
,
Darmendra Ramcharran
4
,
Maju Mathews
5
,
Arun Singh
6
Affiliations
1
Janssen Scientific Affairs, LLC, United States. Electronic address: ekim37@its.jnj.com.
2
Janssen Research and Development, LLC, United States. Electronic address: SGopal2@its.jnj.com.
3
Global Medical Safety, Janssen Research and Development, LLC, United States. Electronic address: aodonne7@ITS.JNJ.com.
4
Global Epidemiology, Janssen Research and Development, LLC, United States. Electronic address: dramchar@ITS.JNJ.com.
5
Janssen Global Medical Affairs, United States. Electronic address: mmathe20@its.jnj.com.
6
Janssen Research and Development, LLC, United States. Electronic address: asing166@ITS.JNJ.com.
PMID:
28818307
DOI:
10.1016/j.ajem.2017.08.012
No abstract available
Keywords:
Paliperidone palmitate; Plasma concentration; Resection.
Publication types
Letter
Comment
MeSH terms
Antipsychotic Agents*
Injections, Intramuscular
Paliperidone Palmitate*
Schizophrenia
Substances
Antipsychotic Agents
Paliperidone Palmitate